Cargando…
The Application Potential and Advance of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction
Myocardial infarction (MI) is a devastating disease with high morbidity and mortality caused by the irreversible loss of functional cardiomyocytes and heart failure (HF) due to the restricted blood supply. Mesenchymal stem cells (MSCs) have been emerging as lead candidates to treat MI and subsequent...
Autores principales: | Wang, Xianyun, Tang, Yida, Liu, Zhao, Yin, Yajuan, Li, Quanhai, Liu, Gang, Yan, Baoyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189813/ https://www.ncbi.nlm.nih.gov/pubmed/34122557 http://dx.doi.org/10.1155/2021/5579904 |
Ejemplares similares
-
Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells
por: Li, Shujing, et al.
Publicado: (2016) -
Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics
por: Ozaki Tan, Sho Joseph, et al.
Publicado: (2020) -
Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction
por: Liu, Yuchang, et al.
Publicado: (2023) -
The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy
por: Wang, Xianyun, et al.
Publicado: (2015) -
MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction
por: Ma, Teng, et al.
Publicado: (2018)